PTC Therapeutics Inc. buy UBS Group AG
Start price
29.07.25
/
50%
€43.60
Target price
29.07.26
€68.98
Performance (%)
48.58%
End price
30.07.26
€64.78
Summary
This prediction ended on 30.07.26 with a price of €64.78. The BUY prediction by UBS_Group_AG for PTC Therapeutics Inc. saw massive gains of 48.58%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| PTC Therapeutics Inc. | 0.963% | 0.963% | 52.718% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% |
Comments by UBS_Group_AG for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at UBS Group AG from $71.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for PTCT provided by MarketBeat
In the thread Trading PTC Therapeutics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.60
03.12.24
03.12.24
€67.48
03.12.25
03.12.25
28.02%
04.12.25
04.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.00
26.08.24
26.08.24
€42.11
26.08.25
26.08.25
34.19%
27.08.25
27.08.25